top of page

Patient Perspective: A conversation with Kasey Woleben and Sophia Zilber

Updated: Aug 27, 2022

Khondrion, a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease, recently sat down with Kasey Woleben, Co-founder, and Sophia Zilber, Board Member and Patient Registry Director of Cure Mito Foundation, to talk about their work and the important role patients play in the research and development of potential new therapies for mitochondrial diseases, particularly via patient registries.

Read more

17 views0 comments

Recent Posts

See All
bottom of page